THERAPY OF ENDOCRINE DISEASE: Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis.

Objective: Beneficial effects of adrenalectomy on cardiovascular risk factors in patients with subclinical Cushing’s syndrome (SCS) are uncertain. We sought to conduct a systematic review and meta-analysis with the following objectives: (i) determine the effect of adrenalectomy compared with conservative management on cardiovascular risk factors in patients with SCS and (ii) compare the effect of adrenalectomy on cardiovascular risk factors in patients with SCS vs those with a nonfunctioning (NF) adrenal tumor. Methods: MEDLINE In-Process & Other Non-Indexed Citations, MEDLINE, EMBASE and Cochrane Central Register of Controlled Trial were searched on 17 November 2015. Reviewers extracted data and assessed methodological quality in duplicate. Results: We included 26 studies reporting on 584 patients with SCS and 457 patients with NF adrenal tumors. Studies used different definitions of SCS. Patients with SCS undergoing adrenalectomy demonstrated an overall improvement in cardiovascular risk factors (61% for hypertension, 52% for diabetes mellitus, 45% for obesity and 24% for dyslipidemia). When compared with conservative management, patients with SCS undergoing adrenalectomy experienced improvement in hypertension (RR 11, 95% CI: 4.3–27.8) and diabetes mellitus (RR 3.9, 95% CI: 1.5–9.9), but not dyslipidemia (RR 2.6, 95% CI: 0.97–7.2) or obesity (RR 3.4, 95% CI: 0.95–12). Patients with NF adrenal tumors experienced improvement in hypertension (21/54 patients); however, insufficient data exist for comparison to patients with SCS. Conclusions: Available low-to-moderate-quality evidence from heterogeneous studies suggests a beneficial effect of adrenalectomy on cardiovascular risk factors in patients with SCS overall and compared with conservative management. 175:6 R283–R295 I Bancos and others Adrenalectomy in subclinical Cushing’s syndrome

[1]  Martin Reincke,et al.  Subclinical hypercortisolism: a state, a syndrome, or a disease? , 2015, European journal of endocrinology.

[2]  M. Vrabel.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses. , 2015, Oncology nursing forum.

[3]  L. Nieman.  Update on subclinical Cushing's syndrome , 2015, Current opinion in endocrinology, diabetes, and obesity.

[4]  M. Debono,et al.  Subclinical hypercortisolism in adrenal incidentaloma , 2015, Current opinion in endocrinology, diabetes, and obesity.

[5]  G. Di Dalmazi,et al.  Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes , 2015, Current opinion in endocrinology, diabetes, and obesity.

[6]  A. Levine,et al.  Adrenal mild hypercortisolism. , 2015, Endocrinology and metabolism clinics of North America.

[7]  W. Richardson,et al.  Long-term outcomes of laparoscopic adrenalectomy for adrenal masses. , 2015, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[8]  D. Nitti,et al.  Systematic review of surgical treatment of subclinical Cushing's syndrome , 2015, The British journal of surgery.

[9]  N. Crabtree,et al.  Longitudinal changes in glucocorticoid metabolism are associated with later development of adverse metabolic phenotype. , 2014, European journal of endocrinology.

[10]  M. Bradburn,et al.  Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. , 2014, The Journal of clinical endocrinology and metabolism.

[11]  T. Carling,et al.  Subclinical Cushing syndrome: a review. , 2014, The Surgical clinics of North America.

[12]  F. Beuschlein,et al.  Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: a systematic review of the literature. , 2014, The Journal of clinical endocrinology and metabolism.

[13]  R. Golfieri,et al.  Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. , 2014, The lancet. Diabetes & endocrinology.

[14]  A. Pontecorvi,et al.  The Role of Adrenal Scintigraphy in the Diagnosis of Subclinical Cushing’s Syndrome and the Prediction of Post-surgical Hypoadrenalism , 2014, World Journal of Surgery.

[15]  E. Ghigo,et al.  Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. , 2014, The Journal of clinical endocrinology and metabolism.

[16]  T. Yanase,et al.  Long-term study of subclinical Cushing's syndrome shows high prevalence of extra-adrenal malignancy in patients with functioning bilateral adrenal tumors. , 2014, Endocrine journal.

[17]  M. Rabijewski,et al.  Bilateral adrenal incidentaloma with subclinical hypercortisolemia: indications for surgery. , 2014, Polskie Archiwum Medycyny Wewnetrznej.

[18]  G. Piaditis,et al.  Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome , 2013, Surgical Endoscopy.

[19]  D. Nitti,et al.  Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome. , 2012, Surgery.

[20]  N. Masumori,et al.  Clinical outcomes of surgical treatment and longitudinal non-surgical observation of patients with subclinical Cushing's syndrome and nonfunctioning adrenocortical adenoma , 2012, Indian journal of urology : IJU : journal of the Urological Society of India.

[21]  C. Mosconi,et al.  Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. , 2012, European journal of endocrinology.

[22]  G. Reimondo,et al.  Subclinical Cushing’s syndrome: definition and management , 2012, Clinical endocrinology.

[23]  T. Yoshimoto,et al.  Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment , 2011, Hypertension Research.

[24]  S. Ito,et al.  Surgical outcomes of laparoscopic adrenalectomy for patients with Cushing’s and subclinical Cushing’s syndrome: a single center experience , 2011, International Urology and Nephrology.

[25]  I. Chiodini.  Diagnosis and Treatment of Subclinical Hypercortisolism , 2011 .

[26]  P. Stewart.  Is subclinical Cushing's syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined. , 2010, The Journal of clinical endocrinology and metabolism.

[27]  M. Copetti,et al.  Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. , 2010, The Journal of clinical endocrinology and metabolism.

[28]  E. Arvat,et al.  Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. , 2010, European journal of endocrinology.

[29]  G. Arnaldi,et al.  Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation , 2010, Surgical Endoscopy.

[30]  K. Schmid,et al.  Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing’s Syndrome , 2010, World Journal of Surgery.

[31]  K. Karlinger,et al.  Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. , 2009, European Journal of Endocrinology.

[32]  A. Toniato,et al.  Surgical Versus Conservative Management for Subclinical Cushing Syndrome in Adrenal Incidentalomas: A Prospective Randomized Study , 2009, Annals of surgery.

[33]  P. Gosse,et al.  [Surgical excision of subclinical cortisol secreting incidentalomas: Impact on blood pressure, BMI and glucose metabolism]. , 2009, Annales d'endocrinologie.

[34]  K. Takano,et al.  Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome. , 2008, Endocrine journal.

[35]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[36]  Han-Zhong Li,et al.  [Subclinical Cushing's syndrome:analysis of diagnosis and surgical effect]. , 2007, Zhonghua wai ke za zhi [Chinese journal of surgery].

[37]  F. Nwariaku,et al.  "Subclinical Cushing's syndrome" is not subclinical: improvement after adrenalectomy in 9 patients. , 2007, Surgery.

[38]  Masayuki Takahashi,et al.  Indications for laparoscopic adrenalectomy for non‐functional adrenal tumor with hypertension: Usefulness of adrenocortical scintigraphy , 2006, International journal of urology : official journal of the Japanese Urological Association.

[39]  Y. Erbil,et al.  Evaluation of the Cardiovascular Risk in Patients with Subclinical Cushing Syndrome Before and After Surgery , 2006, World Journal of Surgery.

[40]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[41]  P. Miccoli,et al.  Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. , 2003, European journal of endocrinology.

[42]  B. Biondi,et al.  Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. , 2002, The Journal of clinical endocrinology and metabolism.

[43]  P. Paccotti,et al.  Adrenal incidentaloma: a new cause of the metabolic syndrome? , 2002, The Journal of clinical endocrinology and metabolism.

[44]  Tsuyoshi Watanabe,et al.  The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection , 2001, Clinical endocrinology.

[45]  L. del Viscovo,et al.  Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. , 2000, The Journal of clinical endocrinology and metabolism.

[46]  Y. Jo,et al.  Preclinical Cushing’s syndrome: Report of seven cases and a review of the literature , 2000, International journal of urology : official journal of the Japanese Urological Association.

[47]  M. Reincke.  Subclinical Cushing's syndrome. , 2000, Endocrinology and metabolism clinics of North America.

[48]  G. Arnaldi,et al.  A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. , 2000, The Journal of clinical endocrinology and metabolism.

[49]  G. Krestin,et al.  Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. , 1992, The Journal of clinical endocrinology and metabolism.

[50]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.